The Journal of Phytopharmacology, 2022;11(4):295-299 ;   DOI: 10.31254/phyto.2022.11413

Review Article

Dillenia pentagyna Roxb.: A Review on Phytochemistry and Pharmacology

Hari Om Saxena¹ , Asima Das¹ , Samiksha Parihar¹

Hari Om Saxena,Asima Das,Samiksha Parihar

1. NWFP Section, Silviculture, Forest Management and Agroforestry Division, Tropical Forest Research Institute, Jabalpur (M.P.) - 482021, India

*Author to whom correspondence should be addressed.

Received: 5th June, 2022 / Accepted: 16th July, 2022

Abstract

---

Dillenia pentagyna often known as ‘Karmal’ is a member of Dilleniaceae. Different parts of the planthave been used by tribal communities to treat a broad spectrum of ailments. The plant reports thepresence of some vital therapeutic compounds such as botulin, botulinic acid, botulinic acid, morolicacid, lupeol, diploic acid, etc. Some of the major pharmaceutical properties of the plant are anticancerous, anti-fungal, anti-bacterial, and anti-diabetic. This plant has been recently classified as acritically endangered species in Madhya Pradesh state. Low germination rates are one of the majorfactors of being a critically endangered species. Despite being a potent curative plant species, it is yet tobe fully explored. The objective of the present review to highlight the phytochemical investigations andpharmacology applications for several purposes like anti-diabetic, anti-cancerous, anti-microbial, antioxidant, etc of this plant species. In future studies, this knowledge can be applied to the safe andevidence-based use of traditional Indian medicinal plants in global Phyto pharmacotherapy and to thediscovery of novel leads for the development of herbal formulations.

Keywords

Dillenia Pentagyna, Phytochemicals, Pharmacological Potential

---